U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations – 2016 Update. Geneva: World Health Organization; 2016.

Cover of Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations – 2016 Update

Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations – 2016 Update.

Show details

Annex 4Health interventions in prisons: a literature review

.

Author Information and Affiliations

Date: 2014-03

1. Background and introduction

HIV remains a serious problem in prison settings. HIV prevalence continues to be higher in prisons than in the general population, although prevalence varies geographically. While most of the prisoners living with HIV or AIDS in prison contract their infection outside of prison walls, the risk of being infected, in particular through sharing of contaminated injecting equipment and through unprotected sex, is great (2007 document). High risk behaviour, including injection drug use, sexual activity, and tattooing/body piercing is widespread within prison settings leading to transmission of HIV and HCV. Several studies have demonstrated that HIV prevention programmes, including education, condom distribution, OST, and needle and syringe programmes, can be successfully implemented in prisons and other closed settings.

In 2007, as part of the writing of the Effectiveness of Intervention to Address HIV in Prisons an extensive literature review was conducted. During the writing of this document, an abbreviated updated literature review was conducted in 2014 focusing on materials developed between 2007 and 2014. The same search terms used in 2007 were again used in 2014 and included: “prison(s)”, “jail(s)”, “correctional facility(ies)”, “detention center(s)”, “prisoner(s)”, “inmate(s)”, “HIV”, and “human immunodeficiency virus”. These search terms were combined with the focus areas of this document (such as “condoms”, “sexual violence”, “HIV/AIDS education”, “medical male circumcision” etc). Publications including both adults and adolescents were included. Studies and materials presented in English and Spanish were included and an effort was made to collect materials from low-and middle-income countries. The initial search returned a total of 363 publications. After removal of duplicate articles presenting the same intervention, articles prior to 2007, non-relevant articles, and review articles including publications prior to 2007 a total of 70 articles remained and are presented in this report. Results from the 2014 review support the 2007 review. No articles were found directly contradicting publications from the 2007 review, nor the recommendations made in the 2007 report. The 2014 review supports the need for continued research in this area.

For each of the following prison-based HIV prevention focus areas, abbreviated summaries and recommendations are presented from the comprehensive 2007 WHO/UNODC/UNAIDS report, Effectiveness of Interventions to Address HIV in Prisons. Results from the 2014 review are presented below the abbreviated 2007 findings and recommendations and include reference summaries by focus area in tables from the 2014 review. Summaries and recommendations are presented by topic area and include: condoms, drug dependence treatment, HIV/AIDS education, sexual violence, HIV treatment, care, and support, HIV testing and counselling, and needle and syringe programmes. Unless noted otherwise, recommendations and findings apply to both adults and adolescent prisoners. For more detailed reading, the 2007 document can be obtained on the WHO website (http://whqlibdoc.who.int/hiv/pub/idu/prisons_effective/en/).

Terminology: In 2007 and again in this update, the term “prison” has been used for all places of detention and the term “prisoner” has been used to describe all who are held in such places, including adult and juvenile males and females detained in criminal justice and prison facilities during the investigation of a crime; while awaiting trial; after conviction and before sentencing; and after sentencing.

2. Health Interventions in Prisons

2.1. Condoms

As stated in the 2007 document, there is evidence that provision of condoms is feasible in a wide range of prison settings. It has been found that condom access is unobtrusive to the prison routine, represents no threat to security or operations, does not lead to an increase in sexual activity or drug use and is accepted by most prisoners and prison staff once it is introduced. At the same time, there is evidence that making condoms available to prisoners is not enough – they need to be easily accessible and in various locations throughout the prison.

The 2014 updated review supports the current recommendations and continues to demonstrate that access to condoms does not increase sexual activity,1, 2 nor are condoms a threat to staff security;3 condoms do however decrease transmission of HIV.4 Continued acceptance of access to condoms by prisoners and staff was found.1, 5 Condoms should be delivered in an easily accessible manner3,5 and delivery in combination with HIV prevention education is encouraged.6,7

2007 Recommendations

  1. Prison authorities in jurisdictions where condoms are currently not provided should introduce condom distribution programmes and expand implementation to scale as soon as possible.
  2. Condoms should be made easily and discreetly accessible to prisoners so that they can pick them up at various locations in the prison, without having to ask for them and without being seen by others.
  3. Together with condoms, water-based lubricant should also be provided since it reduces the probability of condom breakage and/or rectal tearing, both of which contribute to the risk of HIV transmission.
  4. Education and informational activities for prisoners and for staff should precede the introduction of condom distribution programmes, which should be carefully prepared.
  5. Female prisoners should have access to condoms as well as dental dams.
CountryStudySummary
USASylla M, et al (2010)Likelihood of obtaining condoms increased after machine installation; sexual activity did not increase; staff acceptance of condom access increased.
ThailandWilson D, et al (2007)Increasing acceptance of condom distribution among guards outside of health units was challenging.
USALeibowitz AA, et al (2012)Condom distribution programme estimated to avert 25% of HIV transmissions among MSM inmates in K6G unit; condom distribution currently limited to one per week per prisoner.
AustraliaButler T, et al (2013)Availability of condoms not associated with an increase in sexual activity. Condoms more likely to be used when available.
AustraliaYap L, et al (2010)Dental dams are not widely used by women prisoners.
South AfricaStephens T, et al (2009)Demonstrated differences in condom use behaviour suggested that future prevention efforts focus on the importance of using condoms to prevent the spread of HIV/AIDS and other STIs.
USAHarawa N, et al (2010)Over half of men reporting have had sex while incarcerated stated they use condoms provided by the jail. Condoms should continue to be provided along with lubricant. Condoms should be easily accessible and without limitations on number of condoms distributed.
AustraliaYap L, et al (2007)Decrease in reports of both consensual male-to-male sex and male sexual assaults five years after the introduction of condoms into prisons. There exists no evidence of serious adverse consequences of distributing condoms and dental dams to prisoners in NSW. Condoms are an important public health measure in the fight against HIV and sexually transmitted diseases; they should be made freely available to prisoners.
USABryan AD, et al (2009)Adolescents received 1 of 3 group-based interventions: combined sexual and alcohol risk reduction (group psychosocial intervention [GPI] and motivational enhancement therapy [GMET]); sexual risk reduction only (GPI); or HIV/STD prevention information only (GINFO). Condom use frequency decreased over time, although GPI and GPI_GMET interventions mitigated this at follow-up assessments. Active interventions were significantly more successful than the GINFO condition and the pattern of effects favored the GPI _ GMET, there were no statistically significant differences between GPI and GPI _ GMET.

2.2. Drug Dependence Treatment

As stated in the 2007 document, there is evidence that OST with methadone is feasible in a wide range of prison settings. Adequate prison-based OST programmes are effective in reducing injecting drug use and associated needle sharing and infections and they have been shown to have additional benefits for the health of prisoners participating in the programmes, for prison systems and for the community. OST may help to reduce risk of overdose deaths upon release; however strategies are needed to ensure continuity in treatment of opioid users as they move between the community and prison systems. It remains crucial to make OST available in prisons because of its role in facilitating delivery of antiretroviral therapy in people who inject drugs.

In contrast to OST, there is little data on the effectiveness of other forms of drug dependence treatment as an HIV prevention strategy, however good quality, appropriate, and accessible treatment has the potential of improving prison security, as well as the health and social functioning of prisoners, and can reduce reoffending, as long as it provides ongoing treatment and support, post-release care and meet the individual needs of prisoners. In addition, reducing the number of people who are in prison or compulsory treatment and rehabilitation centers because of problems related to their drug use must be a priority.

The 2014 updated review supports the current recommendations and continues to demonstrate positive outcomes associated with drug dependence treatment in prisons including a reduction in high risk harmful behaviour and drug use,8-16 although delays in OST implementation in prisons may have a negative impact on the health of prisoners.17 Among studies including opinions of prisoners regarding OST and other drug dependence treatment, prisoners generally favored the availability of such programmes.18-19 Education should be provided in conjunction with or before introduction of OST20 and specific emphasis should be focused on ensuring linkage to treatment at release between prison-based health care and community-based health care to decrease potential relapse.10,12, 15-16

2007 Recommendations

  1. Prison authorities in countries in which OST is available in the community should introduce OST programmes urgently and expand implementation to scale as soon as possible. Particular efforts should be undertaken to ensure that prisoners on OST prior to imprisonment are able to continue this treatment upon imprisonment, without interruption.
  2. In addition to OST, prison authorities should also provide a range of other drug dependence treatment options for prisoners with problematic drug use, in particular for problematic use of other substances such as amphetamines and cocaine.
  3. Prison authorities should devote particular attention to the availability of treatment and social support services for prisoners on their release, and work in collaboration with relevant authorities to ensure that comprehensive aftercare services are available.
  4. States should affirm and strengthen the principle of providing treatment, education and rehabilitation as an alternative to conviction and punishment for drug-related offences are available.
CountryStudySummary
IranAsl RT, et al (2013)Findings of the urine analyses indicated a minimal yet consistent decrease in drug use over the six months. The pre and post- self-administered questionnaire data relayed modest changes in IDU risky behaviours associated with sexual practices; However, many prisoners continued with risky behaviours even when participating in harm reduction measures, such as methadone maintenance therapy.
SpainDe la Fuente L, et al (2012)OST and NEP introduction was a great advance, but the delay (8-25 years) in implementation and low level of NEP coverage could have limited their potential impact on the improvement of the health of incarcerated persons.
MalaysiaBachireddy C, et al (2011)Survey administered to HIV+ current prisoners. Participants were asked about sexual and drug behaviours in 30 days prior to current incarceration. Half (51%) believed OST would be helpful, 33% believed they needed OST after release to prevent relapse, and 70% wanted to learn more about OST. Among those with prior OST experience, 93% stated they would refer friends to treatment suggesting possibility for peer education.
USAMagura S, et al (2009)Participants randomly assigned to either buprenorphine or methadone maintenance. Completion rates were similar; no significant difference was found on post-release relapse between treatment groups.
IranEshrati B, et al (2008)Knowledge about HIV transmission was high among prisoner population; however additional education should be targeted at prisoners to increase perceptions of effectiveness of health benefits of using harm reduction strategies surrounding drug use (i.e. NSP, clean syringes).
SwitzerlandFavrod-Coune T, et al (2013)OST was offered to all drug users entering the detention center and all accepted treatment. Methadone was the preferred treatment. Post-release use continued for almost half of prisoners released. Prescription and use of OST was improved by having trained practitioners provide prescriptions, without restriction.
USAGordon MS, et al (2009)Methadone maintenance, initiated prior to or immediately after release from prison, increases treatment entry and reduces heroin use at 6 months post-release compared to counselling only.
USAKinlock TW, et al (2009)Prisoners were assigned to one of three groups: (a) Counselling Only: counselling in prison, with passive referral to treatment upon release; (b) Counselling + Transfer: counselling in prison with transfer to methadone maintenance treatment upon release; and (c) Counselling + Methadone: counselling and methadone maintenance in prison, continued in the community upon release. Counselling + Methadone participants were significantly less likely than participants in each of the other two groups to be opioid-positive or cocaine-positive.
Puerto RicoGarcia CA, et al (2007)Treatment completers compared with non-completers had significantly greater reductions in self-reported heroin use, cocaine use, and crime and were less likely to be opioid-positive according to urine drug testing.
MultipleHedrich D, et al (2012)(Review) OMT was associated significantly with reduced heroin use, injecting and syringe-sharing in prison if doses were adequate. Pre-release OMT was associated significantly with increased treatment entry and retention after release if arrangements existed to continue treatment. Disruption of OMT continuity, especially due to brief periods of imprisonment, was associated with very significant increases in HCV incidence.
AustraliaShearer J, et al (2007)Oral naltrexone was an unpopular option among opioid-dependent inmates in this study. Agonist treatments were preferred. Funding support for the naltrexone provision was withdrawn after conclusion of study. Recommendation to continue with provision of methadone maintenance or buprenorphine maintenance and counselling.
USASacks JY, et al (2012)Effectiveness of prison-based treatment for women in general and therapeutic treatment in particular in reducing drug use, criminal activity, and exposure to trauma, and increasing mental health functioning and time until re-incarceration was demonstrated among participants.
USASpringer SA, et al (2010)Buprenorphine induction and stabilization was shown to be acceptable, tolerable and an effective treatment to prevent relapse to opiate use in released HIV-infected prisoners. It appears to be effective at maintaining HIV outcomes and potentially decreasing HIV-associated morbidity and mortality.
MalaysiaWickersham JA, et al (2013)Beginning 4 months before release, standardized methadone initiation and dose escalation procedures began with 5 mg daily for the first week and 5 mg/daily increases weekly until 80 mg/day or craving was satisfied. Participants were followed for 12 months post-release at a MMT clinic within 25 kilometers of the prison. Higher doses of MMT at time of release are associated with greater retention on MMT after release to the community.
IndiaUNODC (2013)Retention rates were 98% of OST clients in prison settings. A significant reduction was found in the severity of dependence, craving for drugs and withdrawal symptoms. Decreases in high risk behaviour including injecting drug use, sharing of needles, and unsafe sexual activities were seen. Prison authorities noted improvements in health and personal hygiene among inmates. Challenges included unpredictable stays by prisoners, lack of linkage to community programmes at release, and frequent staff rotation.
USAFreudenberg N, et al (2010)Participants (N= 552) were recruited in city jails and randomly assigned to receive an intensive 30-hour jail/community-based intervention or a single jail-based discharge planning session. All participants were also referred to optional services at a community-based organization (CBO). Assignment to REAL MEN and, independently, use of CBO services, significantly reduced the odds of substance dependence one year after release.

2.3. HIV/AIDS Education

As stated in the 2007 document, there is evidence that well-designed HIV/AIDS information and education programmes can improve prisoners' knowledge about HIV/AIDS. Studies undertaken in a number of countries, including in low and middle income countries, have demonstrated a need for information and education programmes in prisons, and shown that well-designed programmes can improve prisoners' knowledge about HIV/AIDS. Knowledge alone is insufficient, but it is a precursor to protection from infection. A few evaluations have indicated self-reported behavioural change (particularly upon release) as a result of prison-based educational initiatives, but the effectiveness of educational efforts is difficult to measure and it remains largely unknown whether they reduce HIV transmission among prisoners. HIV information and education programmes in prisons are more likely to be effective if developed and delivered by peers. A number of other factors appear to influence the effectiveness of informational and educational interventions including: a) the comprehensiveness of the programme; b) whether it is specific to the needs of the population; c) whether it is appropriate for the average prisoners' reading and comprehension level; d) whether it has been designed with the input of prisoners; e) whether it is instructor-led or peer-based; f) time of offering of the programme; g) method used to distribute information; and h) whether the programme includes pre- and post-test counselling.

The 2014 updated review supports the current recommendations and continues to demonstrate the importance of peer-based HIV/AIDS education.21-22 HIV/AIDS education programmes should be comprehensive,22-29 yet easy to administer.30 Additionally, programmes should include focus on overall stigma reduction.21

2007 Recommendations

  1. Considering that prisons are important settings for informational and educational programmes for both prisoners and staff about HIV and other infectious diseases, prison systems should establish well-designed programmes in all prisons.
  2. Where possible, education delivered for prisoners by the prison system should be supplemented by peer education programmes that have been shown to be more effective in reaching prisoners.
  3. Informational and educational programmes are but one component of an effective programme to manage HIV in prisons and must be supplemented by other programmes. In particular, prisoners must be provided with the prevention measures that enable them to act upon the information they receive.
CountryStudySummary
South AfricaSifunda S, et al (2008)Control group and two experimental groups (Trained HIV- and HIV+ peer educator led groups). Twelve, 1.5 hour intervention sessions conducted over six weeks covering HIV/AIDS, STIs, nutrition, TB prevention and management, alcohol and other drug abuse, sexuality, and manhood/general life skills. Long-term results showed some differences in practicing safer sex and better sexual negotiation skills.
USADerlega VJ, et al (2008)Stigma towards persons living with HIV and inaccurate theories on HIV transmission were seen among inmates. Recommendations included peer-based HIV education programmes to reduce stigma and increase knowledge on HIV transmission.
USAFields J, et al (2008)Comprehensive and peer-based HIV education is critical for programme success.
TaiwanKo NY, et al. (2009)The study findings showed that a brief TTM-based HIV education programme can be effective for drug-dependent inmates. TTM included one-hour lecture on transmission, prevention, symptoms, screening, and treatment of HIV associated with bloodborne viral infections and injection drug use. Included skill-building session on safe injection, needle cleaning, and disinfection, and condom use.
USAMartin S, et al (2008)DVD targeted group was less likely than standard intervention groups to have unprotected sexual intercourse. Feedback shows that intervention must be brief and simple to administer.
USAGrinstead O, et al (2008)Project START showed that enhanced intervention (EI) was more successful than single session intervention (SSI) in reducing sexual risk behaviours. Sessions were conducted by personnel outside of the correctional institution. Incentives were provided at week one and week twelve.
SwitzerlandFluhmann P, et al (2012)HIV and Hep C information was presented to prisoners using a structured information exchange (StIE) model at the beginning of their prison sentence.
USAGoldberg E, et al (2009)Participants were randomly assigned to one of three conditions: education intervention; education intervention with booster; or no systematic intervention. At 6 months, males in the education and booster groups sustained increases in knowledge scores. Females in these groups sustained increased condom attitude scores. Males in the booster group sustained increased prevention attitude scores. Females in the booster group reported more consistent condom use.
USAGurdin J, et al (2008)The intensive, short-term intervention consists of four, one-hour, small-group sessions focusing on health education issues, particularly HIV/AIDS. Following the intervention, programme participants expressed more favorable attitudes toward condoms, and were more likely to use condoms during intercourse, as compared with the comparison group of teens.
USAHurd NM, et al (2010)Examined the effectiveness of an adapted 4-session HIV prevention programme. Participants participated in either the 8- or the adapted 4-session HIVEd programme. Findings indicate participants in both programmes had positive changes at post interview across all study outcomes. No significant differences in changes between participants in the 4- and 8-session programmes were found.
USARobertson AR, et al (2011)Adolescent girls incarcerated in a state reformatory were recruited/assigned to an 18-session health education programme or a time-equivalent HIV prevention programme. Post intervention, HIV risk reduction programme participants demonstrated the acquisition of risk-reduction behaviours and improved condom application skill.

2.4. Sexual Violence

As stated in the 2007 document, there is evidence from countries around the world that rape and other forms of sexual violence occur in prisons. This poses a serious threat to the health of prisoners, psychologically and physically, including the risk of HIV and other sexually transmitted infections. While some prison systems continue to deny the existence of the problem, fail to collect statistical data on sexual violence in prison, and neglect to provide prison staff training in recognizing, preventing, and responding to prisoner sexual violence, other prison systems have shown that it is possible to fundamentally change the way in which sexual violence is addressed in prison, within a relatively short timeframe. These systems typically adopt methods to document incidents of prisoner sexual violence, undertake prevention effort, provide staff training, undertake investigation and response efforts, and provide services to victims, including access to PEP.

The 2014 updated review supports the current recommendations and re-emphasizes that sexual violence does occur in prison settings. Structural interventions such as cameras and involving prison staff in sexual violence prevention31-32 should be implemented and the need to focus on violence prevention and coping in prisons33 is essential. In studies involving prisoner input, the importance of guards in preventing sexual assault was emphasized.34

2007 Recommendations

  1. Prison systems should develop and implement multi-prong strategies for enhancing the detection, prevention, and reduction of all forms of sexual violence in prisons and for the prosecution of offenders.
  2. Formal evaluations of the various components of the policies and programmes to address rape and other forms of sexual violence in prison should be undertaken.
  3. Victims of sexual assault in prison should have access to post-exposure prophylaxis. In addition, prison systems should make PEP available in other cases in which PEP could reduce the risk of HIV transmission after exposure to HIV.
CountryStudySummary
USAKerbs JJ, et al (2007)Older prisoners were found to be at higher risk for victimization than younger counterparts. Prisoners stated a desire for more guards to help with protection.
USARavi A, et al (2007)A high percentage (65%) of women inmates in this sample reported experiencing abuse prior to entering prison. HIV prevention programmes in prisons should focus on violence prevention/coping and the link between HIV and violence.
USALa Vigne, et al (2011)Three separate interventions were piloted for a 12-month period in 2009. Site A adopted an electronic system to track officers' rounds, Site B installed cameras to reduce blind spots and record evidence for investigations, and Site C trained officers in crisis intervention to help improve their interactions with inmates and their ability to identify and prevent violent acts before they occur. At Site A, fewer instances of force were reported. At Site B, violence was perceived as likely to occur among inmates after cameras were installed. At site C, effectiveness was unable to be evaluated due to inmate holding restructuring, however guards reported favorable impression of programme and training and recommended expansion of the programme.
AustraliaYap L, et al (2007)Authors interviewed prison inmates about decreasing rates of sexual assaults in prisons. Changes implemented in prisons as assaults decreased were fewer prisoners per cell, a toilet and shower located in the cell, increasing number of cameras introduced into cells, day rooms, yards, and programme areas, roaming guards rather than stationary posts, and housing of inmates by risk level. Additionally, a duty of care standard has been emphasized among guards. Guards are expected to improve their awareness of their duty of care obligations to victims of prison sexual assaults and prisoners at increased risk of assault.

2.5. HIV Counselling and Testing

As stated in the 2007 document, there is evidence that programmes that make HIV testing and counselling easily accessible to prisoners on entry to prison and throughout incarceration result in increased uptake of testing and counselling. This is particularly true if HIV testing and counselling are part of a comprehensive care and treatment programme for HIV-positive prisoners and if HIV test results are kept confidential and those voluntarily disclosing their HIV-positive status do not face discrimination or abuse. In addition to access to HIV testing and counselling, prisoners need access to the means to protect oneself. Mandatory HIV testing is unethical and there is evidence suggesting that mandatory HIV testing and segregation of HIV-positive prisoners is costly, inefficient, and can have negative health consequences for segregated prisoners.

The 2014 updated review supports the current recommendations and emphasizes the importance of voluntary HIV testing in prisons and the offering of confidential counselling and testing as soon as possible after prison entry to increase the likelihood prisoners are tested and that they receive their results before discharge or transfer.35-40 Additionally, rapid testing also increases the likelihood that prisoners will know their HIV status.41-44 HIV testing, including opt-out testing was accepted by the majority of prisoners and staff in the studies reviewed45-47 and was found to be more effective at case detection in one study comparing opt out and opt in testing among prisoners.48 HIV testing and counselling can be offered in conjunction with other risk reduction services such as provision of condoms and STI screening to increase effectiveness of HIV prevention efforts in prisons.49-50,40 For prisoners nearing release, HIV care and treatment should be made available through community settings.40,44

2007 Recommendations

  1. Prison systems should provide easy access to HIV testing and counselling.
    • In particular, voluntary HIV testing and counselling:
      • should be easily accessible to all prisoners upon entry and during imprisonment
      • should always be confidential, and everyone being tested should give informed consent and receive counselling
      • should be closely linked to access to care, treatment, and support for those testing positive, and be part of a comprehensive HIV programme that includes access to prevention measures.
  2. Prison systems should not adopt policies of mandatory testing and segregation, as they are counterproductive and can have negative health consequences, including for segregated prisoners.
CountryStudySummary
JamaicaAndrinopoulos K, et al (2010)Demonstration project provided mandatory opt-out testing for new prisoners and psychiatric patients and voluntary HIV testing for prisoners >6months. Pre/post-test counselling provided. 63% accepted voluntary testing and 16% refused mandatory opt-out testing. Relatively high rate of acceptance for voluntary testing. Confidentiality was assured and HIV education was provided.
USAArp W (2009)Prisoners were surveyed and asked if they believe inmates should be tested for HIV when they enter prison and when released from prison. Among surveyed inmates, 97% agreed inmates should be given a mandatory test for HIV and 99.7% agreed every inmate should receive treatment for HIV/AIDS when they have tested positive.
USAKavasery R, et al (2009)Male prisoners accepted HIV testing at higher rates when opt-out testing was offered within 24 hours of incarceration.
USAKavasery R, et al (2009)Female prisoners accepted testing in prison at higher rates when opt-out testing was presented immediately (within 24 hours) after incarceration. Prison staff stated they preferred to offer testing immediately because of high turnover rates.
USADuffus WA, et al (2009)Retrospective cohort study demonstrated the lack of routine HIV screening in South Carolina correctional facilities fostered missed opportunities for earlier diagnosis of HIV for inmates. Routine screening and testing should be implemented in prisons to facilitate early diagnosis of HIV.
USAJafa K, et al (2009)HIV diagnosis was delayed among prison inmates because of a lack of testing in prison facilities. The importance of timely diagnosis and appropriate treatment is demonstrated by the high proportion of seroconverters who were infected with drug-resistant strains.
USAJavanbakht M, et al (2007)Prevention programmes existing in the MSM unit include individual level HIV education and prevention, condom distribution, and HIV and STI counselling. Screening resulted in a high prevalence of STIs and HIV.
USABeckwith CG, et al (2010)Only 28% of participants in conventional cohort received HIV test results versus 100% in rapid test cohort. Rapid testing greatly improved the odds of receiving test results.
USAMacgowan R, et al (2009)Rapid testing was able to identify a considerable number or previously undiagnosed cases of HIV infection and greatly improved the number of prisoners receiving their results and the time in which results were delivered.
South AfricaMotshabi LC, et al (2011)Majority of participants were knowledgeable about HIV transmission, however, barriers to preventing testing and counselling include: stigma, discrimination, lack of trust in health care professionals, poor or bad attitudes of health care professionals, and not knowing about availability of VCT. Programmes addressing stigma and discrimination among health care workers should be implemented.
USADe Voux A, et al (2012)Results from the EnhanceLink demonstration project suggest that HIV testing in jails can lead to new diagnoses of HIV infection and that these infections are being diagnosed substantially early on in the course of the disease. Rapid turnover was not found to be an impediment to jail-based HIV screening. Most inmates did not initiate care while detained. Linkage to care after release emphasized.
USABeckwith CG, et al (2011)Staff and key informants interviewed about rapid HIV testing experience. Positive experiences were reported with rapid testing and the method was preferred over conventional testing models. Prisoners were reported to be more compliant when offered rapid testing versus conventional testing and staff workload was reduced. Universal agreement that immediate access to HIV test results is an advantage and benefit of rapid testing, especially with high turnover of prisoners.
USAStrick LB, et al (2011)Change in procedure from testing request to opt-in testing to opt-out testing in Washington State Jails increased testing among inmates from 5% to 72% to 90%, respectively. Opt-out testing was most effective at case detection.
USATartaro C, et al (2012)As part of the testing process, inmates are assured they will receive free medical care during duration of jail stay and those that lack health insurance will receive outpatient treatment from a local service provider upon release. Rapid testing increases the number of inmates receiving test result before discharge. A large percentage of prisoners received their first HIV test in jail.
USATuli K, et al (2009)HIV and syphilis screening and condom distribution programmes were initiated in the MSM unit of the Los Angeles county jail. Modeling indicates that the intervention can avert many sexually transmitted infections at low cost and can save costs in a scenario in which inmates continue to engage in sexual activity as they do outside jail.
MultipleUNODC, UNAIDS, WHO (2009)Review document on HIV testing and counseling in prisons. Evidence and current practices reviewed, minimum requirements for programs are given, and policy framework and recommendations included in the document. Prisons should introduce comprehensive HIV prevention programs that include: information and education, provision of condoms and water-based lubricant, needle and syringe programmes, other measures to decrease sexual transmission, drug dependence treatment, and HIV treatment, care, and support, including provision of ART.

2.6. HIV Care, Treatment, and Support

As stated in the 2007 document, there is evidence that antiretroviral therapy (ART) has significantly decreased mortality due to HIV and AIDS in countries where ART has become accessible. There has been a parallel decrease in the mortality rate among incarcerated individuals in prison systems in those countries. Providing access to ART for those in need in the context of prisons is a challenge, but it is necessary and feasible. Studies have documented that, when provided with care and access to medications, prisoners respond well to ART. Adherence rates in prisons can be as high as or higher than among patients in the community, but the gains in health status made during the term of incarceration may be lost unless careful discharge planning and linkage to community care are undertaken. As ART is increasingly becoming available in developing countries and countries in transition, it will be critical to ensure that it also becomes available in the countries' prison systems.

Ensuring continuity of care from the community to the prison and back to the community, as well as continuity of care within the prison system, is a fundamental component of successful treatment scale-up efforts. Other measures could also have a positive impact on HIV care, treatment and support in prison. These include ensuring that prison health care be appropriately funded and evolve from the “sick call” model employed in many prison systems into a proactive system that emphasizes early disease detection and treatment, health promotion, and disease prevention. In the medium and longer-term, transferring control of prison health to public health authorities could also have a positive impact. Health care in prisons can be delivered more effectively by public health authorities than by prison management, if proper resources are provided and freedom of action of the new prison health authorities is guaranteed.

The 2014 updated review supports the current recommendations and emphasizes the importance of reducing HIV stigma and discrimination inside of prisons.51-54 To increase adherence in prisons, confidentiality should be assured and positive relationships with prison health staff are essential.51-53 To ensure continuation of treatment at release, linkage to community-based care and discharge with an adequate supply of ART are critical.55-58

2007 Recommendations

  1. Prison systems should ensure that HIV-positive prisoners receive care, treatment and support equivalent to that available to people living with HIV in the community, including ART.
  2. As ART becomes increasingly available in low and middle income countries, actors at the international, national, and regional and local levels should ensure that it also becomes available in prisons.
  3. Efforts need to be undertaken by prison authorities, working with the other components of the criminal justice system and with external health authorities and NGOs, to ensure continuity of care, in particular, ART, from the community to the prison and back to the community, as well as within the prison system.
  4. Where OST is available in the community, it should also be available in prisons, so that people on OST and ART are able to access both without interruption.
  5. In the context of efforts to increase access to care and treatment, including ART, prison systems should provide easy access to HIV testing and counselling.
CountryStudySummary
USARoberson DW, et al (2009)Lack of confidentiality (visible medication lines), stigma, access to medication, and strained relationships with prison health staff negatively influenced ART adherence while incarcerated. ART programmes in prison should include inmate input, protection of medical information, and improved relationships between providers and inmates including stigma reduction strategies.
USAFontana L, et al (2007)Prisoners stated a lack of continuum of care between prison and community during release period. Limited interaction and coordination between the two systems was noted. Discharge models for patients with HIV should follow previously demonstrated successful efforts to increase collaboration between prison system and community that increase retention in care.
CanadaSmall W, et al (2009)Delays in obtaining HIV care and treatment were noted. Poor relationships between prison health staff and prisoners negatively impacts adherence to treatment. High levels of stigma influences ability to take medication and resulted in missed doses. Problems ensuring continuity of treatment post-release were identified.
NamibiaShalihu N, et al (2014)Barriers to ART adherence included: insufficient privacy, stigma, lack of support for adherence, insufficient nutritional intake, market value of ARTs to exchange for money or other benefits, discrimination by prison staff, and lack of information about HIV transmission and care.
USAWohl DA, et al (2011)Project BRIGHT randomized control trial found that an intensive case management intervention spanning the periods of incarceration and release of HIV-infected individuals was as effective for released prisoners as a comprehensive pre-release discharge planning programme in terms of accessing medical care over the year following release.
USANunn A, et al (2010)COMPASS programme (intensive case-management programme) positively impacted linkage to HIV care and other services for HIV-positive jail inmates. Programme links HIV-positive jail detainees from Rhode Island jails to HIV care and other clinical and social services in the community. Participants stated programme assisted in preventing drug relapse after prison release.
USAZaller ND, et al (2008)Of all clients in Project Bridge, 45.8% secured housing, 71% were linked to mental health care, and 51% were linked to addiction services. Despite high levels of addiction (97%) and mental health disorders (34% on medication), ex-offenders were retained in health care for a year after being released from incarceration. Regular contact was deemed essential in building trust.
USACatz SL, et al (2011)Interviewees reinforced the need to deliver confidential HIV prevention-related information in prisons to reduce stigma and safety threats. Prisons need to deliver timely updates on HIV prevention and information relating to HIV care in a manner that protects a person's HIV status.
USAPant Pai N, et al (2009)Continuous ART therapy in jail inmate's benefits CD4 cell counts and control of VL especially compared to those who never took ART. Although jail inmates on intermittent ART were more likely to lose CD4 cells and experience higher VL over time than those on continuous ART, CD4 cell loss was slower in these inmates as compared to inmates never on ART.

2.7. Needle and Syringe Exchange Programmes

As stated in the 2007 document, there is evidence that NSPs are feasible in a wide range of prison settings and prison-based NSPs appear to be effective in reducing needle-sharing and resulting HIV infection. Additionally, prison-based NSPs have additional and worthwhile benefits including a reduction in overdose risk and decreased abscesses and they can facilitate referral to drug dependence treatment programmes and lead to an increase in the number of prisoners accessing such programmes. There is no convincing evidence of any major unintended negative consequences. To facilitate the success of NSPs, prisoners need to have easy, confidential access to NSPs, and prisoners and staff should receive information and education about the programmes and be involved in their design and implementation.

The 2014 updated review supports the current recommendations and demonstrates the occurrence of needle sharing in prisons59-60 while including documented cases of reduction in needle sharing practices after the introduction of a NSP,61 potential decrease in drug abuse,62 and a reduction of HIV infection after the introduction of a NSP.63 Prisoners and staff interviewed do not believe that NSPs increase drug use, but that they do improve hygienic living conditions.63

2007 Recommendations

  1. Prison authorities in countries experiencing or threatened by an epidemic of HIV infections among IDUs should introduce needle and syringe programmes urgently and expand implementation to scale as soon as possible.
  2. Additional research about prison-based NSPs should be undertaken to address remaining knowledge gaps.
CountryStudySummary
CanadaMilloy MJ, et al (2013)Analysis of data from a cohort of PWID from 1996-2012 showed that virus levels increased when persons were incarcerated stating hesitancy to disclose HIV status and treatment interruptions and treatment delays, and. Drug use continued while in jail, reinforcing the need for needle exchange programmes in prisons.
USASeal DW, et al (2008)Study participants reported not using HIV prevention measures when using injection drugs. Supports the need for needle exchange and education programmes for HIV prevention.
SpainFerrer-Castro V, et al (2012)In ten years a total of 15,962 syringes were supplied to 429 users and 11,327 (70.9%) were returned. The prevalence of HIV infection decreased from 21% in 1999 to 8.5% in 2009, HCV prevalence from 40% to 26.1%. Most of the inmates and civil servants believe that the programme did not increase intravenous drug use and improves hygienic living conditions in prison.
KyrgyzstanMoller LF, et al (2008)After development of a needle exchange programme in two prisons, needle sharing decreased from 20% to 8% during the study period.
IranRoshanfekt P, et al (2013)Interviews were conducted with prisoners who stated they had received harm reduction services. Research shows that the programmes, including needle and syringe exchange, have a significant effect on reducing the abuse of drugs among the prisoners studied.

References

1.
Sylla M, Harawa N, et al. The first condom machine in a US jail: The challenge of harm reduction in a law and order environment. Am J Public Health. 2010;100(6):982–985. [PMC free article: PMC2866591] [PubMed: 20395583]
2.
Butler T, Richters J, et al. Condoms for prisoners: No new evidence that they increase sex in prison, but they increase safer sex. Sex Transm Infect. 2013;89(5):377–379. [PMC free article: PMC3717589] [PubMed: 23300337]
3.
Yap L, Butler T, et al. Do condoms cause rape and mayhem? The long-term effects of condoms in New South Wales' prisons. Sex Transm Infect. 2007;83(3):219–222. [PMC free article: PMC2659099] [PubMed: 17179163]
4.
Leibowitz AA, Harawa N, et al. Condom distribution in jail to prevent HIV infection. AIDS Behav. 2012;17(8):2695–2702. [PMC free article: PMC3786088] [PubMed: 22555381]
5.
Harawa N, Sweat J, et al. Sex and condom use in a large jail unit for men who have sex with men and male to female transgenders. Journal of Health care for the Poor and Underserved. 2010;21(3):1071–1087. [PMC free article: PMC3820287] [PubMed: 20693745]
6.
Stephens T, Conerly R, et al. HIV/AIDS, STIs, and condom use beliefs among male prison inmates in two South African provinces: Mpumalanga and KwaZulu-Natal. Glob Public Health. 2009;4(5):423–432. [PubMed: 19548157]
7.
Bryan AD, Schmiege J, et al. HIV risk reduction among detained adolescents: A randomized control trial. Pediatrics. 2009;124(6):e1180–e1188. [PMC free article: PMC9017687] [PubMed: 19901006]
8.
Asl RT, Eshrati et al. Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr prison, Iran. Harm Reduction Journal. 2013;10(41) [PMC free article: PMC3883467] [PubMed: 24369092]
9.
Gordon MS, Kinlock TW, et al. A randomized clinical control trial of methadone maintenance for prisoners: Findings at 6 months post-release. Addiction. 2009;103(8):1333–1342. [PMC free article: PMC2582162] [PubMed: 18855822]
10.
Kinlock TW, Gordon MS, et al. A randomized clinical control trial of methadone maintenance for prisoners: Findings at 6 months post-release. J Subst Abuse Treat. 2009;37(3):277–285. [PMC free article: PMC2803487] [PubMed: 19339140]
11.
Garcia CA, Correa GC, et al. Buprenorphine-naloxone treatment for pre-release opioid dependent inmates in Puerto Rico. J Addict Med. 2007;1(3):126–132. [PubMed: 21768947]
12.
Hedrich D, Alves P, et al. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction. 2012;107(3):501–517. [PubMed: 21955033]
13.
Sacks JY, McKendrick K, et al. A randomized clinical trial of a therapeutic community treatment for female inmates: outcomes at 6 and 12 months after prison release. J Addict Dis. 2012;31(3):258–269. [PubMed: 22873187]
14.
Springer SA, Chen S, et al. Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health. 2010;87(4):592–602. [PMC free article: PMC2900572] [PubMed: 20177974]
15.
UNODC. Rolling out of Opioid substitution treatment (OST) in Tihar prisons, India: Scientific Report. UNODC; Vienna: 2013.
16.
Freudenberg N, Ramaswamy M, et al. Reducing drug use, human immunodeficiency virus risk, and recidivism among young men leaving jail: Evaluation of the REAL MEN re-entry program. J Adolesc Health. 2010;47(5):448–455. [PMC free article: PMC2963792] [PubMed: 20970079]
17.
De la Fuente L, Bravo MJ, et al. Evolution of the need and coverage of opioid substitution treatment and needle Exchange programs in Spanish prisons, 1992-2009. Ver Esp Sanid Penit. 2012;14(2):67–77. [PubMed: 22801652]
18.
Bachireddy C, Bazazi AR, et al. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Drug Alc Dep. 2011;116(1-3):151–157. [PMC free article: PMC3084892] [PubMed: 21232882]
19.
Favrod-Coune T, Baroundi M, et al. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland. Swiss Medical Weekly. 2013;1:143. [PubMed: 24186493]
20.
Eshrati B, Asl RT, et al. Preventing HIV transmission among Iranian prisoners: Initial support for providing education on the benefits of harm reduction practices. Harm Reduc Journal. 2008;5(21):1–7. [PMC free article: PMC2443130] [PubMed: 18541032]
21.
Derlega VJ, Winstead BA, et al. AIDS stigma among inmates and staff in a USA state prison. Journal of STD and AIDS. 2008;19(4):259–263. [PubMed: 18482946]
22.
Fields J, Gonzalez I, et al. Learning from and with incarcerated women. 2008
23.
Sifunda S, Reddy PS, et al. The effectiveness of a peer-led HIV/AIDS and STI health education intervention for prison inmates. Health Educ and Behav. 2008;35(4):494–508. [PubMed: 18591222]
24.
Ko NY, Hsu ST, et al. A pilot study of HIV education on readiness to change on substance use, AIDS knowledge, self-efficacy for risk reduction among male drug-dependent inmates. Substance Use and Misuse. 2009;44(3):322–331. [PubMed: 19212924]
25.
Grinstead O, Eldridge G, et al. An HIV, STD, and Hepatitis prevention program for young men leaving prison: Project START. Journal Correctional Health Care. 2008;17(8):2676–2684. [PubMed: 22124581]
26.
Fluhmann P, Wassmer M, et al. Structured Information Exchange on Infectious Diseases for Prisoners. J Correctional Health Care. 2012;18(3):198–209. [PubMed: 22569902]
27.
Goldberg E, Millson P, et al. A human immunodeficiency virus risk reduction intervention for incarcerated youth: a randomized controlled trial. J of Adolesc Health. 2009;44(2):136–145. [PubMed: 19167662]
28.
Gurdin J, Niego S, et al. Rikers Health Advocacy Program (RHAP): An STI/HIV/AIDS prevention program for young men. In: Josefina J, Card T, editors. Model Programs for Adolescent Sexual Health: Evidence-Based HIV, STI, and Pregnancy Prevention Interventions. 2008. pp. 263–271.
29.
Hurd NM, Valerio MN, et al. Adapting an HIV prevention intervention for high-risk, incarcerated adolescents. Health Educ and Behav. 2010;37(1):37–50. [PubMed: 19494058]
30.
Martin S, O'Connell D, et al. Integrating an HIV/HCV brief intervention in prisoner re-entry: results of a multisite prospective study. J of Psychoactive Drugs. 2008;40(4):427–436. [PMC free article: PMC2725408] [PubMed: 19283947]
31.
La Vigne NG, Debus-Sherrill S, et al. Preventing violence and sexual assault in jail: a situational crime prevention approach. Justice Policy Center Brief. 2011
32.
Yap L, Richters J, et al. The decline in sexual assaults in men's prisons in New South Wales: a systems approach. J Interpers Violence. 2011;26(15):3157–3181. [PubMed: 21282119]
33.
Ravi A, Blankenship KM, et al. Women's Health Issues. 2007;17(4):210–216. [PubMed: 17570681]
34.
Kerbs JJ, Jolley JM. Inmate-on-inmate victimization among older male prisoners. Crime and Delinquency. 2007;31(5):385–393.
35.
Kavasery R, Maru DS, et al. Routine opt-out HIV testing strategies in a female jail setting: A prospective controlled trial. PLoS One. 2009;4(11):e7648. [PMC free article: PMC2777332] [PubMed: 19946370]
36.
Duffus WA, Youmans E. Missed opportunities for early HIV diagnosis in correctional facilities. AIDS Patient Care and STDS. 2009;23(12):1025–1032. [PubMed: 19909169]
37.
Jafa K, McElroy P, et al. PLoS One. 2009;4(5):e5416. [PMC free article: PMC2672174] [PubMed: 19412547]
38.
Motshabi LC, Pengpid S, et al. HIV counseling and testing utilization and attitudes of male inmates in a South African prison. Journal of Social Aspects of HIV/AIDS. 2011;8(3):107–114. [PubMed: 23237725]
39.
De Voux A, Spaulding AC, et al. Early identification of HIV: Empirical support for jail-based testing. PLoS One. 2012;7(5):e37603. [PMC free article: PMC3360747] [PubMed: 22662177]
40.
UNODC; UNAIDS; WHO. HIV testing and counseling in prisons and closed settings. 2009. Technical paper. [PubMed: 26203481]
41.
Beckwith CG, Liu T, et al. HIV risk behavior before and after HIV counseling and testing in jail. J Acquir Immune Defic Syndr. 2010;53(4):485–490. [PMC free article: PMC2837107] [PubMed: 20035232]
42.
MacGowan R, Margolis A, et al. Voluntary rapid human immunodeficiency virus (HIV) testing in jails. Sexually Trans Dis. 2009;36(S2):S9–13. [PubMed: 17724428]
43.
Beckwith CG, Bazerman L, et al. An evaluation of routine opt-out rapid HIV testing program in Rhode Island. AIDS Educ Prev. 2011;23(3 0):96–109. [PMC free article: PMC3734962] [PubMed: 21689040]
44.
Tartaro C, Levy MP. An evaluation of an HIV testing program in the jail setting: results and recommendations. The Prison Journal. 2012;93(1):57–79.
45.
Andrinopoulos K, Kerrigan D, et al. Establishment of an HIV/sexually transmitted disease programme and prevalence of infection among incarcerated men in Jamaica. International J of STD and AIDS. 2010;21(2):114–119. [PMC free article: PMC2845978] [PubMed: 20089997]
46.
Arp W. Race, incarceration, and HIV/AIDS in Louisiana: Risky sexual behavior demands mandatory testing. Race, Class and Gender. 2009;16(1-2):228–237.
47.
Kavasery R, Maru DS, et al. A prospective controlled trial of routine opt-out HIV testing in a men's jail. PLoS One. 2009;4(11):e8056. [PMC free article: PMC2777336] [PubMed: 19946371]
48.
Strick LB, MacGowan J, et al. HIV screening of male inmates during prison intake medical evaluation---Washington, 2006-2010. MMWR. 2011;60(24):811–813. [PubMed: 21697805]
49.
Javanbakht M, Murphy R, et al. Sexually transmitted infections and HIV prevalence among incarcerated men who have sex with men, 2000-2005. Sexually Trans Infections. 2007;36(S2):S17–21. [PubMed: 19125146]
50.
Tuli K, Kerndt PR. Preventing sexually transmitted infections among incarcerated men who have sex with men: a cost effectiveness analysis. Sexually Trans Dis. 2009;36(S2):S41–48. [PubMed: 18303352]
51.
Roberson DW, White BL. Factors influencing adherence to antiretroviral therapy for HIV infected female inmates. Journal of the Assoc of Nurses in AIDS Care. 2009;20(1):50–61. [PMC free article: PMC4592129] [PubMed: 19118771]
52.
Small W, Wood E, et al. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21(6):708–714. [PubMed: 19806487]
53.
Shalihu N, Pretorius L, et al. Namibian prisoners describe barriers to HIV antiretroviral therapy adherence. AIDS Care. 2014 epub ahead of print. [PubMed: 24499371]
54.
Catz SL, Thibodeau L, et al. Prevention needs of HIV-positive men and women awaiting release from prison. AIDS Behav. 2011;16(1):108–120. [PMC free article: PMC3428225] [PubMed: 21553252]
55.
Fontana L, Beckerman A. Recently released with HIV/AIDS: primary care treatment needs and experiences. Journal of Health Care for the Poor and Underserved. 2007;18(3):699–714. [PubMed: 17675724]
56.
Wohl DA, Scheyett A, et al. Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav. 2011;15(2):356–364. [PMC free article: PMC3532052] [PubMed: 21042930]
57.
Nunn A, Cornwall A, et al. Linking HIV-positive jail inmates to treatment, care, and social services after release: results from a qualitative assessment of the COMPASS program. J Urban Health. 2010;87(6):954–968. [PMC free article: PMC3005089] [PubMed: 21046470]
58.
Zaller ND, Holmes L, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. Journal of Health Care for the Poor and Underserved. 2008;19(2):522–531. [PubMed: 18469423]
59.
Seal DW, Margolis AD, et al. Substance use and sexual behavior during incarceration among 18-to-29 year old men: prevalence and correlates. AIDS Behav. 2008;12(1):27–40. [PubMed: 17345144]
60.
Milloy MJ, Kerr T, et al. Incarceration is associated with used syringe lending among active injection drug users with detectable plasma HIV-1 RNA: a longitudinal analysis. BMC Infect Dis. 2013;13:565. [PMC free article: PMC3924231] [PubMed: 24289651]
61.
Moller LF, Van Den Bergh BJ, et al. Drug use in prisons in Kyrgyzstan: a study about the effect of health promotion among prisoners. Int Jour of Prisoner Health. 2008;4(3):124–133. [PubMed: 18698527]
62.
Roshanfekt P, Farnia M, et al. The effectiveness of harm reduction programs in seven prisons of Iran. Iranian J Publ Health. 2013;42(12):1430–1437. [PMC free article: PMC4441940] [PubMed: 26060645]
63.
Ferrer-Castro V, Crespo-Leiro MR, et al. Evaluation of a needle exchange program at Pereiro de Aguiar prison (Ourense, Spain): a ten year experience. Rev Esp Sanid Penit. 2012;14(1):3–11. [PubMed: 22437903]
Copyright © World Health Organization 2016.

All rights reserved. Publications of the World Health Organization are available on the WHO website (http://www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (http://www.who.int/about/licensing/copyright_form/index.html).

Bookshelf ID: NBK379683

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...